Nestle logo

Nestle

Last updated January 31, 2026
125
Innovation Areas
3,230
Inventors
16
Collaborations

Bioactive oligosaccharide prebiotic formulations: NestleRecent Research Landscape

Bacterial colonization in the pediatric respiratory tract leads to recurring infection costs and antibiotic resistance. This lever engineers specific carbohydrate structures to inhibit pathogen adhesion and modulate mucosal immunity.

What technical problems is Nestle addressing in Bioactive oligosaccharide prebiotic formulations?

Infant intestinal microbiota dysbiosis

(30)evidences

Imbalances in gut bacterial populations lead to systemic health issues and susceptibility to non-rotavirus diarrhea. Restoring microbial equilibrium prevents pathogen colonization and improves metabolic health.

Delayed enteral feeding tolerance

(7)evidences

Life-threatening gastrointestinal tissue death and systemic inflammation in vulnerable neonates. Preventing this degradation mechanism ensures survival and long-term gut health in high-risk populations.